Join Our Network
Pharmacy / Merchant
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023
Renata PLC · Capsule (Extended Release)
/ Piece
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.
Fluvoxamine Maleate is indicated in-
Obsessive-Compulsive Disorder
Depressive illness
It is also Indicated in-
Panic Disorder
Eating Disorder
Chronic Tension Headache
Fluvoxamine blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT1A autoreceptors. Studies have also demonstrated that fluvoxamine has virtually no affinity for α1- or α2-adrenergic, β-adrenergic, muscarinic, dopamine D2, histamine H1, GABA-benzodiazepine, opiate, 5-HT1, or 5-HT2 receptors, despite having an affinity for binding to σ1 receptors.
Obsessive-Compulsive Disorder:
Adult: Initially 50 mg in the evening for 3-4 days, increasing if necessary to 300 mg daily (over 150 mg in divided doses).
Child: Over 8 years initially 25 mg daily increased if necessary in steps of 25 mg every 3-4 days to max 200 mg daily in divided doses.
Depression:
Adult: Initially 50-100 mg daily in the evening, increased if necessary to 300 mg daily (over 150 mg in divided doses). Usual maintenance dose 100 mg daily.
Child: Not recommended.
Fluvoxamine maleate should not be used concurrently with monoamine oxidase inhibitors, warfarin, benzodiazepines, theophylline, aminophylline, tricyclic antidepressants and alcohol.
Gastrointestinal side effects, anorexia with weight loss (increased appetite and weight gain also reported), hypersensitivity reactions including rash, urticaria, angioedema, arthralgia, myalgia and photosensitivity. Other side effects include dry mouth, nervousness, anxiety, headache, insomnia and sexual dysfunction, palpitation, tachycardia (may also cause bradycardia), rarely postural hypotension, confusion, ataxia, abnormal liver function tests.
Fluvoxamine maleate should be avoided in pregnancy and lactation.
Fluvoxamine maleate should be used with caution in patients with a history of mania, seizures, suicidal tendency, concomitant EOT, cardiac disease, diabetes mellitus, angle-closure glaucoma, history of bleeding disorders (specially gastrointestinal bleeding), hepatic and renal impairment. Fluvoxamine maleate may also impair performance of skilled tasks (driving).
SSRIs & related anti-depressant drugs
Store below 25°C, in a cool & dry place. Keep away from light. Keep out of the reach of children.